Scrip
Mylan obtains licence in settlement of venlafaxine XR patent dispute
10 December 2009
Nancy Faigen
Mylan says that its subsidiary Mylan Pharmaceuticals has entered into a settlement of US patent infringement litigation with Wyeth (now part of
Pfizer) relating to a generic version of Wyeth's extended-release venlafaxine product, Effexor XR. Mylan, along with several other generics firms, now has...
Please Login to read the full article.
10 December 2009
Nancy Faigen
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
FEATURES
- Face-to-Face: Asia-Pacific emerging as the clinical trial hotspot
- Spanish generics industry fights for its future
EVENTS
Today
Berlin, Germany
Today
Berlin, Germany
22 March 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
